- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
Biomarin Pharmaceuticals (NASDAQ:BMRN): Closing price $54.08
BioMarin’s Achondroplasia treatment wins FDA Orphan Drug designation. Shares closed up 0.97 percent on the day at$54.08, and have traded in a 52-week range of $31.91 to $53.84.
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.